Renaissance Capital logo

uniQure Priced, Nasdaq: QURE

Biotech developing gene therapies for the treatment of orphan diseases.

Industry: Health Care

First Day Return: -14.1%

Industry: Health Care

Biotech developing gene therapies for the treatment of orphan diseases.
more less

uniQure (QURE) Performance